In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality - Concepedia

Concepedia

Publication | Closed Access

In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality

18

Citations

0

References

2021

Year

Raina Zhang, Eleftherios Mylonakis

Annals of Internal Medicine

Abstract

Pan H, Peto R, Henao-Restrepo AM, et al. <b>Repurposed antiviral drugs for Covid-19-interim WHO Solidarity Trial results.</b> N Engl J Med. 2020. [Epub ahead of print.] 33264556.